Previous close | 74.96 |
Open | 74.57 |
Bid | 0.00 x 3000 |
Ask | 0.00 x 1200 |
Day's range | 73.55 - 76.34 |
52-week range | 61.28 - 101.24 |
Volume | |
Avg. volume | 737,870 |
Market cap | 6.625B |
Beta (5Y monthly) | 1.29 |
PE ratio (TTM) | N/A |
EPS (TTM) | -4.28 |
Earnings date | 02 Aug 2022 - 08 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 117.39 |
A look at the shareholders of Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) can tell us which group is most powerful...
The FDA places Sarepta's (SRPT) next-generation DMD candidate, SRP-5051, on clinical hold, following a report of hypomagnesemia in the ongoing phase II MOMENTUM study.
Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.